Skip to content

Menu

Network Sub-MenuBrowse by SubjectBrowse by PublisherJoin the NetworkGet StartedSubscribeSupport

Search

Close

Enter Search Terms

Christopher Fanelli

ID: 1b83294d-2619-30fb-68c4

/

Unclaimed

/

Organization: Hogan Lovells

FDA and EMA Address Quality and Manufacturing Challenges for Breakthrough Therapies Undergoing Expedited Approval

Focus on Regulation · August 5, 2019

FDA Finalizes Data Integrity Guidance, With Some Noteworthy Changes

Focus on Regulation · December 12, 2018

FDA publishes internal policy on prioritizing surveillance inspections for drug manufacturing sites

Focus on Regulation · September 5, 2018

FDA to Rely on Drug Inspections Performed by Certain European Regulatory Authorities Beginning November 1, 2017

Focus on Regulation · October 31, 2017

Continuous Manufacturing of Pharmaceuticals: FDA Wants to Hear from Industry

Focus on Regulation · June 23, 2017

Claim This Record

Is this your profile? Upgrade to display your full biography, collected works, social connections, practice areas, and more.

Enhance Your Profile

Call us at 1-800-913-0988 or email sales@lexblog.com.

Facebook LinkedIn Twitter RSS

About LexBlog
The Field We Built
Our Beliefs
Our Team
Contact LexBlog

Disclaimer
Editorial Policy
Terms of Service

Get Started
Publishing Solutions
Compass

Submit a Request
Support Center
System Status

Copyright © 2026, LexBlog, Inc. All Rights Reserved.

Law blog design & platform by LexBlog